Back to Search Start Over

Recommendations and guidelines from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 2 -- Ex vivo imaging

Authors :
Schilling, Kurt G
Grussu, Francesco
Ianus, Andrada
Hansen, Brian
Barrett, Rachel L C
Aggarwal, Manisha
Michielse, Stijn
Nasrallah, Fatima
Syeda, Warda
Wang, Nian
Veraart, Jelle
Roebroeck, Alard
Bagdasarian, Andrew F
Eichner, Cornelius
Sepehrband, Farshid
Zimmermann, Jan
Soustelle, Lucas
Bowman, Christien
Tendler, Benjamin C
Hertanu, Andreea
Jeurissen, Ben
Frydman, Lucio
van de Looij, Yohan
Hike, David
Dunn, Jeff F
Miller, Karla
Landman, Bennett A
Shemesh, Noam
Anderson, Adam
McKinnon, Emilie
Farquharson, Shawna
Acqua, Flavio Dell'
Pierpaoli, Carlo
Drobnjak, Ivana
Leemans, Alexander
Harkins, Kevin D
Descoteaux, Maxime
Xu, Duan
Huang, Hao
Santin, Mathieu D
Grant, Samuel C.
Obenaus, Andre
Kim, Gene S
Wu, Dan
Bihan, Denis Le
Blackband, Stephen J
Ciobanu, Luisa
Fieremans, Els
Bai, Ruiliang
Leergaard, Trygve
Zhang, Jiangyang
Dyrby, Tim B
Johnson, G Allan
Cohen-Adad, Julien
Budde, Matthew D
Jelescu, Ileana O
Publication Year :
2022

Abstract

The value of preclinical diffusion MRI (dMRI) is substantial. While dMRI enables in vivo non-invasive characterization of tissue, ex vivo dMRI is increasingly being used to probe tissue microstructure and brain connectivity. Ex vivo dMRI has several experimental advantages including higher signal-to-noise ratio and spatial resolution compared to in vivo studies, and more advanced diffusion contrasts for improved microstructure and connectivity characterization. Another major advantage is direct comparison with histological data as a crucial methodological validation. However, there are a number of considerations that must be made when performing ex vivo experiments. The steps from tissue preparation, image acquisition and processing, and interpretation of results are complex, with many decisions that not only differ dramatically from in vivo imaging, but ultimately affect what questions can be answered using the data. This work represents 'Part 2' of a series of recommendations and considerations for preclinical dMRI, where we focus on best practices for dMRI of ex vivo tissue. We first describe the value that ex vivo imaging adds to the field of dMRI, followed by general considerations and foundational knowledge that must be considered when designing experiments. We then give guidelines for ex vivo protocols, including tissue preparation, imaging sequences and data processing including pre-processing, model-fitting, and tractography. Finally, we provide an online resource which lists publicly available ex vivo dMRI datasets and dedicated software packages. In each section, we attempt to provide guidelines and recommendations, but also highlight areas for which no guidelines exist, and where future work should lie. An overarching goal herein is to enhance the rigor and reproducibility of ex vivo dMRI acquisitions and analyses, and thereby advance biomedical knowledge.<br />Comment: 59 pages, 12 figures, part of ongoing efforts on ISMRM Diffusion Study Group initiative 'Best Practices (Consensus) for diffusion MRI'. arXiv admin note: text overlap with arXiv:2209.12994

Details

Database :
arXiv
Publication Type :
Report
Accession number :
edsarx.2209.13371
Document Type :
Working Paper